52% and 66% death reduction for molnupiravir and nirmatrelvir–ritonavir users among inpatients with COVID-19
A research team including members from the Department of Pharmacology and Pharmacy, School of Public Health, Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University ...